HORSHAM, Pa.--(BUSINESS WIRE)--Acurian, Inc., a leading, full-service provider of patient recruitment and retention solutions, announced today that it entered into an agreement with pharmaceutical services company i3 to offer improved site identification and selection to its customers. Through the agreement, Acurian will provide site selection support to trial sponsors via i3’s services that offer statistics for improved planning and identification of trial sites with the most patients.
